Did you suffer an eye injury after using Elmiron?

YOU MAY BE ELIGIBLE TO FILE AN INDIVIDUAL CLAIM AGAINST ELMIRON. COMPLETE THE FORM FOR A FREE CASE EVALUATION.

An Elmiron lawsuit is a legal claim for money damages brought by a consumer who took the medication Elmiron to treat a chronic bladder condition called interstitial cystitis.  The lawsuits allege that long-term exposure to Elmiron causes pigmentary maculopathy which is an eye disorder affecting the macula, the central part of the retina, and a major cause of permanent vision loss and blindness.

Recently dozens of individuals from across the United States have filed Elmiron Lawsuits with the help of experienced attorneys alleging that their use of Elmiron has caused retinal injuries and vision damage, notably atypical or pigmentary maculopathy.  Elmiron’s medication insert did not include any warning regarding vision issues or eye disease until a warning was added about pigmentary maculopathy in June of 2020. These lawsuits (often referred to as mass torts) have are seeking compensation for Elmiron victims from the drug manufacturers and have been consolidated into the Elmiron MDL (multidistrict litigation).  The Elmiron MDL is in the discovery phase of the case and is being handled in the United States District Court District of New Jersey before Judge Brian Martinotti and Judge Edward Kiel.  Soon, some these Elmiron MDL cases will be selected to proceed as bellwether trials and will have a large influence on the remaining Elmiron MDL cases.

If you or a loved one has been suffered vision loss after taking Elmiron, contact the aggressive defective drug lawsuit lawyer Matthew Marin of Marin and Barrett, Inc. to find out how we can help.  Matthew Marin has been ranked as a top lawsuit attorney by the SuperLawyers organization as a “Rising Star” and now a “SuperLawyer” from 2014 through 2020. Call to schedule a free, no obligation case evaluation today. Our personal injury lawyers are available 24/7 at (888) 348-2735 to take your call and stand ready to fight for the money you need and deserve.

Our Elmiron Attorneys are evaluating claims and accepting clients who meet the following basic criteria:

1) You took Elmiron on a daily basis for 6 months or longer; and
2) After your use of Elmiron you experienced vision problems, visual symptoms, or other common symptoms and were diagnosed with one or more of the following conditions:

Did you suffer an eye injury after using Elmiron?

YOU MAY BE ELIGIBLE TO FILE AN INDIVIDUAL CLAIM AGAINST ELMIRON. COMPLETE THE FORM FOR A FREE CASE EVALUATION.

A) Pigmentary maculopathy / macular retinopathy
B) Age-related macular degeneration
C) Retinal dystrophy
D) Other retinal conditions

WHAT IS ELMIRON?

Elmiron, or pentosan polysulfate sodium, is an oral prescription drug used to treat discomfort or bladder pain associated with interstitial cystitis, or IC, a chronic condition that causes bladder conditions such as pain and pressure.  The most common side effects of Elmiron are hair loss, diarrhea and nausea.  Occasionally, headache, abdominal pain, and upset stomach may occur.

DOES ELMIRON CAUSE BLINDNESS?

First reported in the American Academy of Opthalmology, new studies have provided evidence linking the common bladder medication Elmiron to a vision-threatening eye condition.  The most recent study conducted by three ophthalmologists involved a review of patients at Kaiser Permanente in Northern California.  The study revealed that one-quarter of patients with significant exposure to Elmiron showed definite signs of eye damage, and that the medication toxicity could masquerade as other known retinal conditions, such as age-related macular degeneration or pattern dystrophy.

If you or a loved one suffered an eye or vision injury after using Elmiron,
call an Elmiron Lawyer at Marin and Barrett, Inc. today at (888) 348-2735 for a free,
no obligation consultation. We can help with your Elmiron lawsuit. You can also fill out our
one-minute questionnaire below to find out whether you have a claim.
Contact Us For A Elmiron Case Evaluation

WHO MAKES ELMIRON?

Janssen Pharmaceuticals manufactures Elmiron and the U.S. Food and Drug Administration originally approved it for sale in 1996.  It is currently the only oral drug approved to treat bladder pain and discomfort associated with IC (interstitial cystitis), and it is not available in generic.  It is estimated that hundreds of thousands of people have used Elmiron and that most users are women.  Other defendants have been included in the recent Elmiron Lawsuits including:

  • Janssen Pharmaceuticals, Inc.;
  • Bayer Corporation;
  • Bayer Healthcare LLC
  • Bayer Healthcare Pharmaceuticals, Inc.;
  • Bayer US LLC;
  • Teva Branded Pharmaceutical Products R&D;
  • Teva Pharmaceuticals USA, Inc.;
  • IVAX LLC;
  • Baker Norton U.S., Inc.;
  • Baker Norton Pharmaceuticals, Inc.

WHAT IS THE ELMIRON LAWSUIT?

The Elmiron lawsuits claim the drug causes an eye disorder called maculopathy and other disorders of the retina that may lead to blindness. Individuals who took Elmiron and suffered maculopathy or other serious vision problems may be eligible to join the Elmiron lawsuit.  If successful, you may be entitled to financial compensation for damages, including:

  • Past, present, and future medical expenses
  • Lost wages and lost earning potential
  • Pain and suffering
  • Compensation for loss of vision
  • Loss of consortium
  • Punitive damages, if appropriate

Unfortunately, many thought taking Elmiron was a safe and effective way to treat their IC. Elmiron’s medication insert did not include any warning regarding retinal damage or an increased risk of eye disease until Janssen Pharmaceuticals added a warning about pigmentary maculopathy in June 0f 2020. For this reason, the Elmiron lawsuit attorneys are seeking compensation and a fair settlement for Elmiron victims who are suffering from vision problems including blurred vision, maculopathy, retinopathy, and vision impairment through the Elmiron MDL.

ELMIRON LAWYERS

The Pharmaceutical Industry is an international financial powerhouse, spending $1.2 trillion worldwide and $485 billion in the United States alone in 2018. Do not go it alone, let us fight them for you to get the compensation you rightfully deserve. We work hand in hand with some of the most experienced and respected law firms nationwide and have the resources your case needs to stand toe to toe with pharmaceutical giants.  We know that the retinal damage caused by the long-term use of pentosan polysulfate sodium for painful bladder syndrome can lead to large medical bills.  Our Elmiron lawsuit lawyers and our skilled legal team can help you take legal action by gathering your medical bills, medical records, and the testimony of medical professionals to show that the pentosan polysulfate caused your eye condition and that you were not warned of the potential risks when you first started taking this dangerous drug.

At Marin and Barrett, Inc. we firmly believe that the client’s needs come above all else and have established a fully transparent fee structure to reflect that. We work on a strictly contingency fee basis, meaning that we do not receive anything from you unless we are able to recover money either by settlement or verdict. Regardless of what type of case you have or what is required, you will know everything up front with no surprises. We shoulder the costs of the filing and litigation on your behalf and at no risk to you until we are able to achieve a fair settlement for you.

Call our Elmiron attorneys Marin and Barrett, Inc. today (888) 348-2735 to schedule your free consultation, it only takes a few moments and there is no obligation.

ATTORNEY MATTHEW MARIN

Admitted in Rhode Island, Connecticut, Massachusetts and South Carolina​

ATTORNEY KENSLEY BARETT

Admitted in Rhode Island and Massachusetts

ATTORNEY NICHOLAS PARRILLO

Admitted in Rhode Island and Massachusetts

ELMIRON DISCLAIMER: Do not stop taking a prescribed medication without first consulting with your doctor. Discontinuing a prescribed medication without your doctor’s advice can result in injury or death.